VANGL2 and uterine cancer: The results of the CPTAC dataset (Figure 1B) showed higher expression of VANGL2 total protein in the primary tissues of brain cancer, LUSC, uterine cancer (p < 0.0001) and ovarian cancer (p < 0.001) than in normal tissues.